INCYSUS THERAPEUTICS TO PRESENT AT THE 2020 SOLEBURY TROUT VIRTUAL INVESTOR CONFERENCE

NEW YORK, April 06, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (Incysus), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta () T cell immunotherapy for the treatment of cancers, today announced that the Company will present at the 2020 Solebury Trout Virtual Investor Conference on Tuesday, April 7th.